72 related articles for article (PubMed ID: 6429616)
1. [Action of pristinamycin on Chlamydia].
Orfila J; Haider F
Pathol Biol (Paris); 1984 May; 32(5):443-5. PubMed ID: 6429616
[TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo activity of spiramycine on Chlamydia (author's transl)].
Orfila J; Haider F; Thomas D
Pathol Biol (Paris); 1982 Jun; 30(6):449-51. PubMed ID: 7050851
[TBL] [Abstract][Full Text] [Related]
3. The effector of antibiotics on the Chlamydia family.
Orfila J; Laurans G
Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (1):7-82. PubMed ID: 7178707
[No Abstract] [Full Text] [Related]
4. [Evaluation of in vitro activity of pristinamycin against Haemophilus influenzae].
Dabernat H
Pathol Biol (Paris); 1993 Sep; 41(7):641-6. PubMed ID: 8255616
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
Fremaux A; Sissia G; Geslin P
Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of the macrophages of inbred strain mice to Chlamydia psittaci].
Orfila J; Haider F; Bissac E
Bull Eur Physiopathol Respir; 1983; 19(2):147-9. PubMed ID: 6871493
[TBL] [Abstract][Full Text] [Related]
8. [Use of an experimental Chlamydia trachomatis salpingitis model for evaluating the effectiveness of antibiotics and anti-inflammatory agents on fertility].
Verhoest P; Orfila J; Bissac E
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):309-14. PubMed ID: 9265054
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo activity of roxithromycin against Chlamydia trachomatis.
Furneri PM; Sardo S; Cianci A; Palumbo G; Tempera G
J Chemother; 1991 Jan; 3 Suppl 1():36-8. PubMed ID: 12041782
[TBL] [Abstract][Full Text] [Related]
10. [Structure-activity relationship of semi-synthetic derivatives of the PIA component of pristinamycin].
Paris JM; Rolin O; Corbet JP; Cotrel C; Bouanchaud DH
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):493-6. PubMed ID: 3937125
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
12. Examination of the treatment and follow-up care for adolescents who test positive for Chlamydia trachomatis infection.
Hwang LY; Tebb KP; Shafer MA; Pantell RH
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1162-6. PubMed ID: 16330741
[TBL] [Abstract][Full Text] [Related]
13. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
15. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds.
Barrière JC; Bouanchaud DH; Paris JM; Rolin O; Harris NV; Smith C
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():1-8. PubMed ID: 1399940
[TBL] [Abstract][Full Text] [Related]
17. A Role for the glycolipid exoantigen (GLXA) in chlamydial infectivity.
Vora GJ; Stuart ES
Curr Microbiol; 2003 Mar; 46(3):217-23. PubMed ID: 12567246
[TBL] [Abstract][Full Text] [Related]
18. [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].
Bernard P; Risse L; Bonnetblanc JM
Ann Dermatol Venereol; 1996; 123(1):16-20. PubMed ID: 8734110
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes].
Dubreuil L; Houcke I; Singer E
Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928
[TBL] [Abstract][Full Text] [Related]
20. Role of Tryptophan supplementation in the treatment of Chlamydia.
Singla M
Med Hypotheses; 2007; 68(2):278-80. PubMed ID: 17045416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
